Imagine a child recovers from a severe blood condition in the hospital but is still very fragile. To stop them from getting sick again and returning to the ward, they need a specific course of medicine at home. This work figures out the best way to get those pills to families—using things like text reminders and community helpers—to make sure the medicine is actually taken.
High rates of hospital readmission and death among children with severe anaemia in Africa due to a lack of a structured system to deliver preventative medicine after they leave the hospital.
A set of delivery strategies involving community health workers and SMS reminders, supported by cost-effectiveness data and national policy guidelines.
If you are a drug manufacturer dealing with low patient adherence in emerging markets — this project developed delivery strategies and adherence data that can increase the effective usage of antimalarials. This helps ensure that the 77% reduction in post-discharge deaths is achieved in real-world settings.
If you are a software provider dealing with poor medication compliance in rural areas — this project developed and tested automated SMS reminders for 1,824 children. This provides a proven model for scaling digital health interventions in Benin and Kenya.
If you are a consultancy dealing with inefficient health service delivery — this project developed cost-effectiveness data and policy guidelines for PDMC. This allows you to offer evidence-based implementation plans to ministries of health in endemic regions.
Based on available project data, the specific unit cost per child is not provided, but the project evaluates the cost-effectiveness of different delivery strategies.
Yes, the project is specifically designed to translate results into national policy guidelines to promote uptake into clinical practice across four endemic countries.
Based on available project data, there is no mention of patents; the focus is on implementation research and public health policy guidelines.
The project runs from July 2023 to December 2026, with 18 months dedicated to trial implementation.
It integrates via community health workers and automated SMS reminders, co-designed with national health ministries.
The consortium is heavily research-oriented, consisting of 7 partners across 6 countries. It is led by a French research institute (IRD) and includes 5 research organizations and 2 universities. There is a 0% industry ratio, indicating the project is currently in the public health evidence-generation phase rather than a commercial product phase.
Contact the Institut de Recherche pour le Développement (IRD) in France.
Contact us to access the cost-effectiveness data for malaria chemoprevention delivery.
